KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Inventory Average (2016 - 2026)

Amgen has reported Inventory Average over the past 17 years, most recently at $6.2 billion for Q1 2026.

  • For Q1 2026, Inventory Average fell 9.59% year-over-year to $6.2 billion; the TTM value through Mar 2026 reached $6.2 billion, down 9.59%, while the annual FY2025 figure was $6.6 billion, 19.94% down from the prior year.
  • Inventory Average for Q1 2026 was $6.2 billion at Amgen, down from $6.3 billion in the prior quarter.
  • Over five years, Inventory Average peaked at $9.1 billion in Q1 2024 and troughed at $4.2 billion in Q1 2022.
  • A 5-year average of $6.2 billion and a median of $6.3 billion in 2025 define the central range for Inventory Average.
  • Biggest five-year swings in Inventory Average: skyrocketed 83.5% in 2024 and later fell 24.75% in 2025.
  • Year by year, Inventory Average stood at $4.8 billion in 2022, then soared by 50.14% to $7.3 billion in 2023, then fell by 1.27% to $7.2 billion in 2024, then decreased by 12.46% to $6.3 billion in 2025, then decreased by 1.27% to $6.2 billion in 2026.
  • Business Quant data shows Inventory Average for AMGN at $6.2 billion in Q1 2026, $6.3 billion in Q4 2025, and $6.5 billion in Q3 2025.